DAVID N GILL Insider Trading $EOLS Evolus, Inc.
Get free email notifications about insider trading for DAVID N GILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID N GILL. DAVID N GILL is Senior Vice President and CFO in CTI MOLECULAR IMAGING INC ($CTMI) and in STRATA Skin Sciences, Inc. ($MELA) and Director in STRATA Skin Sciences, Inc. ($MELA) and Director in HISTOGENICS CORP ($HSGX) and Director in CEMPRA, INC. ($CEMP) and Director in Evolus, Inc. ($EOLS) and Chief Financial Officer in EndoChoice Holdings, Inc. ($GI) and President and CFO in EndoChoice Holdings, Inc. ($GI) and Director in Strongbridge Biopharma plc ($SBBP) and Director in Y-mAbs Therapeutics, Inc. ($YMAB).
DAVID N GILL in Evolus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID N GILL: Director
Holdings: 24,313 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID N GILL in Evolus, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTMI, GI, EOLS, MLNT, HSGX, MELA, SBBP, YMAB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Grant | A | 0.00 | 19,313 | 0 | 24,313 | 5 K to 24.3 K (+386.26 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jun 14 2019 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | P | 13.65 | 2,000 | 27,300 | 5,000 | 3 K to 5 K (+66.67 %) |
| Jan 25 2019 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 16.19 | 14,500 | 234,755 | 14,500 | |
| Dec 17 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | P | 12.77 | 3,000 | 38,300 | 3,000 | 0 to 3 K |
| Dec 17 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | P | 12.77 | 3,000 | 38,300 | 3,000 | 0 to 3 K |
| Apr 26 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 8.01 | 22,696 | 181,795 | 22,696 |
Page: 1